Lasa Supergenerics Limited (LASA.BO)
INR 17.71
(2.25%)
INR 17.71
(2.25%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 220.76 Million INR | 1.41% |
| 2022 | 217.69 Million INR | 7.93% |
| 2021 | 201.7 Million INR | 3.64% |
| 2020 | 194.63 Million INR | -59.87% |
| 2019 | 484.94 Million INR | -43.7% |
| 2018 | 861.38 Million INR | -22.6% |
| 2017 | 1.11 Billion INR | -7.05% |
| 2016 | 1.19 Billion INR | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | - INR | -100.0% |
| 2023 Q2 | 10.55 Million INR | 0.0% |
| 2023 Q4 | 220.76 Million INR | 0.0% |
| 2023 FY | 220.76 Million INR | 1.41% |
| 2023 Q3 | - INR | -100.0% |
| 2023 Q1 | - INR | -100.0% |
| 2022 Q2 | 215.93 Million INR | 0.0% |
| 2022 FY | 217.69 Million INR | 7.93% |
| 2022 Q1 | - INR | -100.0% |
| 2022 Q3 | - INR | -100.0% |
| 2022 Q4 | 217.69 Million INR | 0.0% |
| 2021 Q2 | 262 Thousand INR | 0.0% |
| 2021 FY | 201.7 Million INR | 3.64% |
| 2021 Q3 | - INR | -100.0% |
| 2021 Q4 | 201.7 Million INR | 0.0% |
| 2021 Q1 | - INR | -100.0% |
| 2020 Q4 | 194.63 Million INR | 0.0% |
| 2020 Q1 | - INR | -100.0% |
| 2020 Q3 | - INR | -100.0% |
| 2020 Q2 | 72.7 Million INR | 0.0% |
| 2020 FY | 194.63 Million INR | -59.87% |
| 2019 Q2 | 620.92 Million INR | 0.0% |
| 2019 Q3 | - INR | -100.0% |
| 2019 FY | 484.94 Million INR | -43.7% |
| 2019 Q4 | 484.94 Million INR | 0.0% |
| 2019 Q1 | - INR | -100.0% |
| 2018 Q4 | 861.38 Million INR | 0.0% |
| 2018 FY | 861.38 Million INR | -22.6% |
| 2018 Q2 | 885.73 Million INR | 0.0% |
| 2018 Q1 | - INR | -100.0% |
| 2018 Q3 | - INR | -100.0% |
| 2017 Q1 | - INR | 0.0% |
| 2017 Q2 | 681.13 Million INR | 0.0% |
| 2017 Q3 | - INR | -100.0% |
| 2017 Q4 | 1.11 Billion INR | 0.0% |
| 2017 FY | 1.11 Billion INR | -7.05% |
| 2016 FY | 1.19 Billion INR | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Bajaj HealthCare Limited | 3.32 Billion INR | 93.367% |
| Glenmark Life Sciences Limited | 171.48 Million INR | -28.739% |
| Hester Biosciences Limited | 2.44 Billion INR | 90.966% |
| Lupin Limited | 29.21 Billion INR | 99.244% |
| Medicamen Biotech Limited | 308.17 Million INR | 28.364% |
| Medico Remedies Limited | 80.5 Million INR | -174.225% |
| NATCO Pharma Limited | 3.71 Billion INR | 94.053% |
| Achyut Healthcare Limited | - INR | -Infinity% |
| Ajanta Pharma Limited | 352.8 Million INR | 37.426% |
| Alkem Laboratories Limited | 14.18 Billion INR | 98.444% |
| Alpa Laboratories Limited | 52.46 Million INR | -320.78% |
| Alembic Pharmaceuticals Limited | 5.13 Billion INR | 95.698% |
| AstraZeneca Pharma India Limited | 45.98 Million INR | -380.105% |
| Aurobindo Pharma Limited | 66.47 Billion INR | 99.668% |
| Brooks Laboratories Limited | 56.41 Million INR | -291.29% |
| Divi's Laboratories Limited | 30 Million INR | -635.873% |
| Dr. Reddy's Laboratories Limited | 20.02 Billion INR | 98.897% |
| Eris Lifesciences Limited | 27.81 Billion INR | 99.206% |
| FDC Limited | 205.18 Million INR | -7.592% |
| Glenmark Pharmaceuticals Limited | 12.3 Billion INR | 98.207% |
| Granules India Limited | 13.15 Billion INR | 98.321% |
| Gufic Biosciences Limited | 3.32 Billion INR | 93.369% |
| Indoco Remedies Limited | 6.71 Billion INR | 96.715% |
| Ind-Swift Laboratories Limited | 166.21 Million INR | -32.816% |
| Ipca Laboratories Limited | 14.38 Billion INR | 98.465% |
| Jagsonpal Pharmaceuticals Limited | 89.41 Million INR | -146.91% |
| Krebs Biochemicals & Industries Limited | 1.93 Billion INR | 88.587% |
| Laurus Labs Limited | 25.77 Billion INR | 99.143% |
| Mankind Pharma Limited | 2.07 Billion INR | 89.344% |
| Megasoft Limited | 1.47 Billion INR | 84.987% |
| Procter & Gamble Health Limited | 95.6 Million INR | -130.923% |
| Piramal Pharma Limited | 47.1 Billion INR | 99.531% |
| RPG Life Sciences Limited | - INR | -Infinity% |
| Sigachi Industries Limited | 1.43 Billion INR | 84.568% |
| Sun Pharma Advanced Research Company Limited | 611.5 Million INR | 63.898% |
| Sun Pharmaceutical Industries Limited | 32.73 Billion INR | 99.326% |
| Suven Pharmaceuticals Limited | 649.96 Million INR | 66.035% |
| Syncom Formulations (India) Limited | 724.86 Million INR | 69.544% |
| Unichem Laboratories Limited | 2.47 Billion INR | 91.081% |
| Windlas Biotech Limited | 36.41 Million INR | -506.322% |
| ZIM Laboratories Limited | 1.08 Billion INR | 79.714% |
| Zydus Lifesciences Limited | 8.04 Billion INR | 97.255% |
| Bliss GVS Pharma Limited | 998.4 Million INR | 77.888% |
| Wanbury Limited | 1.16 Billion INR | 81.048% |
| Amrutanjan Health Care Limited | 17.28 Million INR | -1177.336% |
| Bal Pharma Limited | 1.39 Billion INR | 84.192% |
| Strides Pharma Science Limited | 25.16 Billion INR | 99.123% |
| Venus Remedies Limited | 413.3 Million INR | 46.586% |
| Aarti Pharmalabs Limited | 2.85 Billion INR | 92.261% |
| Nectar Lifesciences Limited | 6.35 Billion INR | 96.526% |
| Shilpa Medicare Limited | 9.37 Billion INR | 97.645% |
| Aarti Drugs Limited | 5.64 Billion INR | 96.088% |
| IOL Chemicals and Pharmaceuticals Limited | 327.6 Million INR | 32.612% |
| Suven Life Sciences Limited | 7.09 Million INR | -3010.638% |
| Ind-Swift Limited | 10.13 Billion INR | 97.823% |
| Valiant Laboratories Limited | 767.08 Million INR | 71.221% |
| J. B. Chemicals & Pharmaceuticals Limited | 3.77 Billion INR | 94.154% |
| Solara Active Pharma Sciences Limited | 10.11 Billion INR | 97.817% |
| Themis Medicare Limited | 957.92 Million INR | 76.954% |
| Hikal Limited | 8.17 Billion INR | 97.3% |
| Torrent Pharmaceuticals Limited | 40.22 Billion INR | 99.451% |
| Sequent Scientific Limited | 4.87 Billion INR | 95.473% |
| Novartis India Limited | 69.7 Million INR | -216.732% |
| Wockhardt Limited | 23.56 Billion INR | 99.063% |
| Jubilant Pharmova Limited | 36.64 Billion INR | 99.397% |
| Biofil Chemicals and Pharmaceuticals Limited | 4.38 Million INR | -4929.893% |
| Neuland Laboratories Limited | 953.89 Million INR | 76.857% |
| Morepen Laboratories Limited | 289.99 Million INR | 23.873% |
| Kilitch Drugs (India) Limited | 316.46 Million INR | 30.241% |
| Mangalam Drugs & Organics Limited | 984.92 Million INR | 77.586% |